The most recent public comments will be considered by the DSM-5 work groups. Then the draft versions of the diagnostic criteria will move to the next level of review, which includes the Assembly and the Board of Trustees. Roger Peele, M.D., has represented the Assembly on the DSM-5 Task Force. The Assembly Committee on DSM-5, chaired by Glenn Martin, M.D., has begun reviewing the draft versions of the criteria and the supporting text. This round of review will focus particularly on clinical utility, which has been the highest priority guiding the DSM-5 development process. Any changes from DSM-IV to DSM-5 should have a positive impact on clinical practice. The Assembly Committee on DSM-5 will be interacting with the DSM-5 Task Force, the full Assembly, and the Board of Trustees. While our work will be thorough, our deliberations must adhere to a strict timeline. DSM-5 is scheduled to be published in time for the May 2013 annual meeting in San Francisco.